SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001050470-12-000019
Filing Date
2012-02-03
Accepted
2012-02-02 17:49:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 PAR PHARMA lsv13g123111parpharma.txt SC 13G 8129
  Complete submission text file 0001050470-12-000019.txt   9724
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Subject) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-46121 | Film No.: 12567195
SIC: 2834 Pharmaceutical Preparations

Mailing Address 155 NORTH WACKER DRIVE SUITE 4600 CHICAGO IL 60606
Business Address 155 NORTH WACKER DRIVE SUITE 4600 CHICAGO IL 60606 312-460-2443
LSV ASSET MANAGEMENT (Filed by) CIK: 0001050470 (see all company filings)

IRS No.: 232772200 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G